Visit WTR Logo
Subscribe now

Life Sciences

Downward trend in US patent litigation continues; Big Tech gets busier at the PTAB

Lawsuit filings and inter partes review petitions both fell in 2018, but operating companies’ share of the action was on the rise 

Downward trend in US patent litigation continues; Big Tech gets busier at the PTAB
18 Jan 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.

17 Jan 2019

University domination of the biologics patent landscape points way to heightened deal-making in the coming years

New report shows research institutions dominate the field, with UCAL, Johns Hopkins, Stanford, the NIH, Harvard and Singapore’s Agency for Science Technology & Research leading the way between 2015 and 2018

Latest

View all
16 Jan 2019

New collaboration between leading IP brands set to boost global patent transactions

IAM Market teams up with Richardson Oliver Insights to deliver new tranche of assets to its IP buying, selling, licensing and tech transfer platform being offered by top brokers Read more

16 Jan 2019

Five things you must know about CRISPR

An insider’s guide to how it has revolutionised the life sciences patent landscape - and will continue to do so Read more

15 Jan 2019

Indian IP jurisprudence is the real winner in the Monsanto cotton technology case

Supreme Court decision does not bring any clarity to the technical issues at stake, but it does establish clear rules for how judges should handle complex patent suits Read more

14 Jan 2019

The ultimate success of the Bristol-Myers’ Celgene purchase could hinge on one upcoming trial

Biggest life sciences M&A deal for nearly two decades may turn out to be a damp squib if Dr Reddy’s wins a suit relating to follow-on patents that cover flagship cancer treatment Revlimid   Read more

News

View all
21 Dec 2018

Life sciences round-up - UK Supreme Court rules in landmark case, patent linkage shelved in China, big CAFC decision and much more

A summary of the major IP news from the biotechnology, pharmaceutical and medical technology sectors in November and the first-half of December Read more

12 Dec 2018

Supreme Court of India set to rule in crucial plant innovation dispute

The decision in Monsanto’s appeal against the revocation of a key patent right could have profound implications on the ability to protect agro-biotech inventions in India Read more

4 Dec 2018

All the action from the final day of IPBC Asia 2018

This year's event in Shanghai has now come to an end. It's been a great couple of days, including the IP Asia Elite Gala Dinner and Awards held last night Read more

3 Dec 2018

IPBC Asia Day One report - all the highlights from another sell-out event

How Chinese courts will rule the patent world; Qualcomm's 5G licensing spree; don't jail trolls, says former supreme court judge; patent sales are on the up; plus a whole lot more from a wet, but spectacular, Shanghai Pudong Read more

Analysis

View all
10 Jan 2019

Iancu-inspired subject matter guidance meets with industry approval, but may make Congressional action less likely

After heavy trailing by the USPTO Director, agency proposes new details on issue of abstract ideas just as the Supreme Court turns its attention to “blockbuster” 101 Fed Circuit case Read more

8 Jan 2019

Monsanto prevails in closely-watched Indian Supreme Court case

Reports say the top court upheld the patentability of novel genetically lab-engineered chemical entities like the company's blockbuster Bt cotton variety Read more

21 Dec 2018

Senator Hatch’s proposal to limit biopharma IPRs has come at the wrong time

Lame duck session attempt at reform looks likely to fail given recent changes at the PTAB and growing public concern over drugs pricing in the US Read more

20 Dec 2018

MIT and Harvard lead the world’s research institutions in patent quality, but look out for the rise of China  

The research centres which produce the most world-leading assets are currently found in the US and Europe, but analysis shows that Chinese universities are beginning to catch up (Picture: MIT) Read more

Trending

1

The ultimate success of the Bristol-Myers’ Celgene purchase could hinge on one upcoming trial

2

Patents, platform technologies and new therapeutic modalities

3

US pharma patents are under greater threat than ever before

4

Five things you must know about CRISPR

5

Indian IP jurisprudence is the real winner in the Monsanto cotton technology case

We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.